Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Diabetes Reports|September 16, 2015
New and emerging biomarkers in cardiovascular diseaseLeah E Cahill, Monica L Bertoia, Sarah A Aroner, et al.
Breast Cancer Research : BCR|August 10, 2010
Columnar cell lesions and subsequent breast cancer risk: a nested case-control studySarah A Aroner, Laura C Collins, Stuart J Schnitt, et al.
Journal of Clinical Medicine|November 4, 2020
Associations of HDL Subspecies Defined by ApoC3 with Non-Alcoholic Fatty Liver Disease: The Multi-Ethnic Study of AtherosclerosisJakub Morze, Manja Koch, Sarah A Aroner, et al.
Cancer|November 14, 2015
Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses' Health StudiesLaura C Collins, Sarah A Aroner, James L Connolly, et al.
Cancer Causes & Control : CCC|September 17, 2014
Plasma matrix metalloproteinase 1, 3, and 7 levels and breast cancer risk in the Nurses' Health studySarah A Aroner, Bernard A Rosner, Rulla M Tamimi, et al.
Cancer Epidemiology|March 25, 2015
Plasma matrix metalloproteinase 2 levels and breast cancer riskSarah A Aroner, Bernard A Rosner, Rulla M Tamimi, et al.
Journal of the American Heart Association|March 16, 2018
High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III and Subclinical Atherosclerosis Measures: MESA (The Multi-Ethnic Study of Atherosclerosis)Sarah A Aroner, Manja Koch, Kenneth J Mukamal, et al.
American Journal of Epidemiology|May 19, 2017
Apolipoprotein C-III and High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III in Relation to Diabetes RiskSarah A Aroner, Ming Yang, Junlong Li, et al.
Pageof 2